AveXis

AveXis is a biotechnology company focused on developing gene therapies for patients with rare and life-threatening neurogenetic diseases. At the core of AveXis is the establishment of unique industry and research alliances that will bring innovative therapies to people with unmet medical needs. Spinal Muscular Atrophy (SMA), a rare/orphan disease, is AveXis' primary focus.